SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc regeneration. The procedure was completed in under 15 minutes using a local anesthetic, and the patient was discharged within an hour.
SpinalCyte received Institutional Review Board approval to commence the randomized, placebo-controlled, double-blind Phase I clinical trial with CybroCell dermal fibroblast cell product in late 4Q16.
SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc regeneration. The procedure was completed in under 15 minutes using a local anesthetic, and the patient was discharged within an hour.
SpinalCyte received Institutional Review Board approval to commence the randomized,...
SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc regeneration. The procedure was completed in under 15 minutes using a local anesthetic, and the patient was discharged within an hour.
SpinalCyte received Institutional Review Board approval to commence the randomized, placebo-controlled, double-blind Phase I clinical trial with CybroCell dermal fibroblast cell product in late 4Q16.
Copy to clipboard 
